Dr. Marina D'Enza

Cross-functional program management for an innovative digital healthcare solution for Alzheimer’s disease management Ensure a coordinated and integrated execution of the different work streams External business partners management and budget control Creation and maintenance of integrated project plans Responsibility for the project risks assessment, critical path analysis, timelines and milestones Project reporting to stakeholders and leadership

Line management responsibility on the International Affairs Business Unit: Regulatory Affairs, Marketing and Customer Support (15 people) Management of the B2B international distribution network Strategic contracting for key business partnerships Portfolio: in-vitro diagnostic immunoassays for point of care and clinical chemistry in the areas of autoimmunity, rare diseases (IBD, neuropathies, allergies). Benchtop instruments, innovative solutions for self-diagnostics including an App for mobile phones

Portfolio planning Plan and execution of a large “voice of customer” program to identify gaps and opportunities in Tecan B2B portfolio M&A case study for the acquisition of a manufacturer for key components (acquisition in 2006) Key strategic partnerships Launch of targeted sales initiatives for new projects acquisition Strategic key accounts analysis and identification of sales opportunities Creation and management of a cross-departmental CI (customer intelligence) and market insights report

Roll-out strategy, market access strategy for Straumann Allografts (implantable human-derived biomaterials) and full launch execution in the US market. Leadership on a European-North American cross-functional subject matter expert team Product development, global commercial and clinical marketing for Straumann PURE Ceramic Implant and Straumann Bone Ceramic Establishment of “train the trainer” and product demonstration concepts and programs. Reporting to stakeholders, KOL management

Roll-out strategy, market access strategy for Synthes implantable human-derived biomaterials and full launch execution in several European countries. Leadership on a highly qualified subject matter expert team to face complex unexplored market-specific regulations for the solution products Establishment of train the trainer and product demonstration programs. Reporting to stakeholders, KOL management Tenfold increase of Synthes human-derived bone substitutes

Business development responsibility for the sales territory Switzerland. Clientele: pharmaceutical industry, hospitals, academics. Products: reagents, software, capital equipment (CHF 100’000/pcs) for diagnostics and research Goals: customer acquisition and development, technical product demonstrations, local promotions and product exhibitions Awards: Top Performance New Products and Top Sales Performance Europe.

Genetics of microorganisms, biodegradation of toxic substances